Godino M, Romera V, Sanchez-Tomero J, Pacheco J, Canals S, Lerma J
J Clin Invest. 2013; 123(10):4359-63.
PMID: 23999426
PMC: 3784528.
DOI: 10.1172/JCI67284.
Zhao H, Joo S, Xie W, Ji X
Int J Physiol Pathophysiol Pharmacol. 2013; 5(2):61-72.
PMID: 23750305
PMC: 3669735.
Mousavi S, Saadatnia M, Khorvash F, Hoseini T, Sariaslani P
Arch Med Sci. 2012; 7(3):465-9.
PMID: 22295030
PMC: 3258743.
DOI: 10.5114/aoms.2011.23413.
Schnell L, Hunanyan A, Bowers W, Horner P, Federoff H, Gullo M
Eur J Neurosci. 2011; 34(8):1256-67.
PMID: 21995852
PMC: 3195885.
DOI: 10.1111/j.1460-9568.2011.07862.x.
de Vasconcellos-Bittencourt A, Vendite D, Nassif M, Crema L, Frozza R, Thomazi A
Neurochem Res. 2011; 36(5):793-800.
PMID: 21253855
DOI: 10.1007/s11064-011-0404-7.
Role of cannabinoids and endocannabinoids in cerebral ischemia.
Hillard C
Curr Pharm Des. 2008; 14(23):2347-61.
PMID: 18781985
PMC: 2581413.
DOI: 10.2174/138161208785740054.
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.
Dravid S, Erreger K, Yuan H, Nicholson K, Le P, Lyuboslavsky P
J Physiol. 2007; 581(Pt 1):107-28.
PMID: 17303642
PMC: 2075223.
DOI: 10.1113/jphysiol.2006.124958.
Ca2+ -permeable acid-sensing ion channels and ischemic brain injury.
Xiong Z, Chu X, Simon R
J Membr Biol. 2006; 209(1):59-68.
PMID: 16685601
DOI: 10.1007/s00232-005-0840-x.
Failure of ischemic neuroprotection by potentiators of gamma-aminobutyric acid.
Madden K, Clark W, Lessov N
Clin Med Res. 2005; 1(2):119-24.
PMID: 15931298
PMC: 1069034.
DOI: 10.3121/cmr.1.2.119.
Brain tissue responses to ischemia.
Lee J, Grabb M, Zipfel G, Choi D
J Clin Invest. 2000; 106(6):723-31.
PMID: 10995780
PMC: 381398.
DOI: 10.1172/JCI11003.
Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death.
Ying H, Weishaupt J, Grabb M, Canzoniero L, Sensi S, Sheline C
J Neurosci. 1998; 17(24):9536-44.
PMID: 9391008
PMC: 6573419.
Management of acute ischemic stroke. An update for primary care physicians.
Albers G
West J Med. 1997; 166(4):253-62.
PMID: 9168683
PMC: 1304205.
Reorganization in the auditory cortex of the rat induced by intracortical microstimulation: a multiple single-unit study.
Maldonado P, Gerstein G
Exp Brain Res. 1996; 112(3):420-30.
PMID: 9007544
DOI: 10.1007/BF00227948.
A behavioral model of excitotoxicity: retinal degeneration, loss of vision, and subsequent recovery after intraocular NMDA administration in adult rats.
Sabel B, Sautter J, Stoehr T, Siliprandi R
Exp Brain Res. 1995; 106(1):93-105.
PMID: 8542981
DOI: 10.1007/BF00241359.
Glycine site of the excitatory amino acid N-methyl-D-aspartate receptor in neonatal and adult brain.
DSouza S, McConnell S, Slater P, BARSON A
Arch Dis Child. 1993; 69(2):212-5.
PMID: 8215523
PMC: 1029459.
DOI: 10.1136/adc.69.2.212.
Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation.
Valtysson J, Hillered L, Andine P, Hagberg H, Persson L
Acta Neurochir (Wien). 1994; 129(1-2):58-63.
PMID: 7998497
DOI: 10.1007/BF01400874.
Dextrorphan attenuates the behavioral consequences of ischemia and the biochemical consequences of anoxia: possible role of N-methyl-d-aspartate receptor antagonism and ATP replenishing action in its cerebroprotecting profile.
Himori N, Tanaka Y, Kurasawa M, Mishima K, Akaike N, Imai M
Psychopharmacology (Berl). 1993; 111(2):153-62.
PMID: 7870946
DOI: 10.1007/BF02245517.
Behavioral studies on FR115427, a novel selective N-methyl-D-aspartate antagonist.
Nakanishi H, KATSUTA K, Ueda Y, Takasugi H, Kuno A, Ohkubo M
Psychopharmacology (Berl). 1995; 117(2):172-7.
PMID: 7753964
DOI: 10.1007/BF02245184.
Prophylaxis and treatment of stroke. The state of the art in 1993.
Sila C
Drugs. 1993; 45(3):329-37.
PMID: 7682904
DOI: 10.2165/00003495-199345030-00002.
Ketamine and strychnine treatment of an infant with nonketotic hyperglycinaemia.
Roth B, Gunther M, Theisohn M, Heinemann U, Adams H, Sticht G
Eur J Pediatr. 1995; 154(8):649-53.
PMID: 7588967
DOI: 10.1007/BF02079070.
